| Name | EquityMethodInvestmentDeferredGainOnSale |
|---|---|
| Namespace | http://fasb.org/us-gaap/2020-01-31 |
| Prefix | us-gaap |
| Data type | xbrli:monetaryItemType |
| Period type | duration |
| Substitution Group | xbrli:item |
| Balance | credit |
| Nillable | True |
| Abstract | False |
| Text | Lang | Role | Container role |
|---|---|---|---|
| Equity Method Investment, Deferred Gain on Sale | en-US | http://www.xbrl.org/2003/role/label | http://www.xbrl.org/2003/role/link |
| This element represents disclosure of the amount of gain which has been deferred as the result of the sale of a business or operating assets to a highly leveraged entity which deferred gain has been reflected in the accompanying statement of financial position as reduction from the related asset. | en-US | http://www.xbrl.org/2003/role/documentation | http://www.xbrl.org/2003/role/link |